Abstracts by key term: Pharma information campaigns in Europe
In the modern imagination, the patient is an active contributor to his or her health. The paradigm shift from accepting to co-determining patients is leading to a redefinition of relationships and behavior in healthcare. Since the doctor largely controls the demand for medical services and products through his medical expertise and information advantage, patients have limited sovereignty from the outset. Politicians and health insurance companies therefore hope that the critical, co-determining patient will have an influence on the system that has so far been controlled by the service providers. What this co-determination on the part of patients could look like was developed in two further studies (Cope 1+2), among others in collaboration with representatives of the European Parliament. This approach showed in which areas and under which conditions chronically ill people could actively contribute to improving our health system.
